Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 26, Issue 21, pp. 5621-5630
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 26, 2020
- Revision received July 7, 2020
- Accepted August 14, 2020
- Published first August 18, 2020.
Article Versions
- Previous version (August 18, 2020 - 06:20).
- Previous version (September 24, 2020 - 06:27).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Diane M. Da Silva1,*,
- Danielle M. Enserro2,3,
- Jyoti S. Mayadev4,
- Joseph G. Skeate5,
- Koji Matsuo1,
- Huyen Q. Pham1,
- Heather A. Lankes6,7,
- Katherine M. Moxley8,
- Sharad A. Ghamande9,
- Yvonne G. Lin1,
- Russell J. Schilder10,
- Michael J. Birrer11, and
- W. Martin Kast1,5
- 1Department of Obstetrics & Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.
- 2Clinical Trial Development Division, NRG Oncology, Philadelphia, Pennsylvania.
- 3Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- 4Department of Radiation Medicine and Applied Sciences, UC San Diego Medical Center, La Jolla, California.
- 5Department of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California.
- 6Operations Center-Philadelphia East, NRG Oncology, Philadelphia, Pennsylvania.
- 7Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
- 8Department of Obstetrics & Gynecology, Oklahoma University Health Science Center, Oklahoma City, Oklahoma.
- 9Department of Gynecology/Oncology, Augusta University Medical Center, Augusta, Georgia.
- 10Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
- 11Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
- ↵*Corresponding Author:
Diane M. Da Silva, University of Southern California, 1450 Biggy Street, Mail Code 9601, Los Angeles, CA 90033-9601. Phone: 323-442-3868; Fax: 323-442-7760; E-mail: Diane.DaSilva{at}med.usc.edu
November 2020
Volume 26, Issue 21
Volume 26, Issue 21
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)
Jump to section
Advertisement